AHA Letter on Drug Price Transparency Bill

AHA letter to Ways and Means Committee on the Prescription Drug Sunshine, Transparency, Accountability and Reporting Act (H.R. 2113.

Related Resources

Special Bulletin
Member
Leaders of the Senate Committee on Health, Education, Labor and Pensions (HELP) May 23 released the Lower Health Care Costs Act of 2019 – bipartisan discussion…
Testimony
Public
AHA testimony before the House Committee on Ways and Means Subcommittee on Health on Hearing on Protecting Patients from Surprise Medical Bills
Letter/Comment
Public
AHA applauds the U.S. House of Representatives for considering the Strengthening Health Care and Lowering Prescription Drug Costs Act.
Letter/Comment
Public
AHA letter to Representative Kilmer expressing support of H.R. 2552, the “Protecting Local Access to Care for Everyone Act.” 
Testimony
Public
Statement of the American Hospital Association for the Committee on Rules
Letter/Comment
Public
AHA letter to Senator Richard J.